CBDV

CBDV (Cannabidivarin) is a non-psychoactive cannabinoid found in Cannabis. It is a homolog of CBD, with the side-chain shortened by two methylene bridges (CH2 units). Plants with relatively high levels of CBDV have been reported in feral populations of C. indica from northwest India, and in hashish from Nepal.

Chemistry

CBDV differs from CBD through the substitution of a pentyl chain with a propyl chain on the molecule. This difference in molecular structure significantly changes the pharmacology of CBDV compared to CBD. Like the rest of the plant cannabinoids, CBDV is an acidic cannabinoid that is decarboxylated with heat, light, or alkaline conditions to yield cannabidivarin.

Pharmacology

CBDV does not have any psychoactive effects and is not scheduled by Convention on Psychotropic Substances. It is thought to affect the functioning of the Endocannabinoid system, which regulates a variety of physiological processes and helps maintain homeostasis in the body.

Medical Research

Research into the pharmacology of CBDV is not as robust as more commonly known cannabinoids such as THC or CBD. However, initial studies suggest that it may have use in the treatment of epilepsy and other neurological conditions. It is also being investigated for its potential anti-inflammatory and anti-nausea effects.

See Also

• Cannabinoid
• Cannabis (drug)
• Cannabidiol
• Tetrahydrocannabinol

CBDV Resources
Latest articles Most recent articles Ongoing trials	Wikipedia